Memorializing Governor Kathy Hochul to proclaim May 12, 2026, as Fibromyalgia Awareness Day in the State of New York
This resolution memorializes Governor Kathy Hochul to proclaim May 12, 2026, as Fibromyalgia Awareness Day in New York State. It is a ceremonial measure that recognizes fibromyalgia as a chronic syndrome affecting millions of people and describes the condition’s symptoms, including widespread pain, fatigue, sleep problems, cognitive difficulties, and other debilitating effects. The resolution also emphasizes the lack of a known cause or cure, the difficulty many patients face in obtaining a diagnosis, and the need for greater public and medical awareness.
The resolution further highlights the social and economic burdens associated with fibromyalgia, including treatment costs, workplace impacts, and the challenges patients face in obtaining appropriate care and accommodations. It references the work of the International Institute For Human Empowerment and the Fibromyalgia Task Force of New York State, and encourages broader education, advocacy, and collaboration among patients, physicians, researchers, employers, educators, and policymakers. The measure asks that copies be sent to various state and medical institutions, reinforcing its awareness-raising purpose rather than creating a regulatory program.
As a Senate resolution, this measure does not amend the Public Health Law or any other statute, create new rights or obligations, or appropriate funding. Its legal effect is limited to memorializing the Governor to issue a proclamation designating Fibromyalgia Awareness Day and to formally recognizing the condition and the people affected by it. The practical impact is symbolic and educational, aimed at increasing awareness among state agencies, medical professionals, employers, and the public.
The overall sentiment reflected in the resolution is strongly supportive and sympathetic toward people living with fibromyalgia. The bill’s language frames the condition as serious, under-recognized, and often misunderstood, and it urges public support for research, treatment, and patient assistance. Because there were no recorded committee transcripts or votes provided, there is no evidence of formal opposition in the available record.
The resolution itself does not present direct policy conflict, but it identifies several areas of concern that could be contentious in broader discussions: the adequacy of medical training, whether physicians are sufficiently prepared to diagnose and treat fibromyalgia, the lack of workplace accommodations, and the absence of legal protections or reliable prevalence data. The text also suggests disagreement or skepticism in the medical community, noting that many physicians find the condition difficult to treat and that some patients report being refused care. These issues are raised as problems to be addressed through awareness and education rather than through binding legislation.